The impact of the incidence of diabetic complications on mortality in colorectal cancer patients with diabetes: A nationwide study

被引:1
作者
Lee, Woo-Ri [1 ]
Han, Kyu-Tae [2 ]
Chang, Yoon Jung [3 ]
Park, Seojin [2 ]
Kim, Woorim [2 ]
机构
[1] Natl Hlth Insurance Serv Ilsan Hosp, Dept Res & Anal, 100 Ilsan Ro, Goyang 10444, South Korea
[2] Natl Canc Control Inst, Natl Canc Ctr, Div Canc Control & Policy, 323 Ilsan Ro, Goyang 10408, South Korea
[3] Natl Canc Ctr, Natl Canc Control Inst, Natl Canc Survivorship Ctr, 323 Ilsan Ro, Goyang 10408, South Korea
关键词
Diabetes; Diabetic complications; Type 2 diabetes mellitus; Colorectal cancer; Mortality; RISK; MELLITUS; DISEASE; PROGNOSIS; INDEX; TERM;
D O I
10.1007/s00384-023-04509-3
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
PurposeThe prevalence of diabetes is higher in patients with colorectal cancer, which is important because diabetes is recognized as a risk factor for increased mortality. This study investigated the impact of incident diabetes-related complications on all-cause five-year mortality in older aged colorectal cancer patients with diabetes.MethodsThe 2008 to 2019 National Health Insurance Service data on the elderly were used to identify patients with colorectal cancer aged 60 years or above diagnosed with type 2 diabetes mellitus. The outcome measure was all-cause five-year mortality. The main independent variable was incident status of diabetes-related complications using the Diabetes Complications Severity Index (DCSI). Survival analyses were performed using the Cox proportional hazards model, in addition to the calculation of risk differences. Subgroup analysis was conducted based on the type of complication and DCSI scores.ResultsAmong 1,312 individuals, 319 (24.3%) died within five years after one year of a cancer diagnosis. The risk of mortality was higher in patients with diabetes and cancer having incident diabetes-related complications (Hazard Ratio 1.29, 95% Confidence Interval 1.03-1.63). These tendencies were generally maintained regardless of the type of complication and DCSI scores.ConclusionThe incidence of diabetes-related complications after cancer diagnosis was associated with an increased risk of all-cause five-year mortality in older patients with colorectal cancer and preexisting diabetes.
引用
收藏
页数:10
相关论文
共 38 条
[1]   Immortal Time Bias in Observational Studies of Time-to-Event Outcomes: Assessing Effects of Postmastectomy Radiation Therapy Using the National Cancer Database [J].
Agarwal, Parul ;
Moshier, Erin ;
Ru, Meng ;
Ohri, Nisha ;
Ennis, Ronald ;
Rosenzweig, Kenneth ;
Mazumdar, Madhu .
CANCER CONTROL, 2018, 25 (01)
[2]   Incidence of age migration of colorectal cancer in younger population: Retrospective single centred-population based cohort study [J].
Ahmed, Safia Zahir ;
Cirocchi, Nicholas ;
Saxton, Edward ;
Brown, Miss Katherine .
ANNALS OF MEDICINE AND SURGERY, 2022, 74
[3]   Postoperative Mortality in Cancer Patients With Preexisting Diabetes Systematic review and meta-analysis [J].
Barone, Bethany B. ;
Yeh, Hsin-Chieh ;
Snyder, Claire F. ;
Peairs, Kimberly S. ;
Stein, Kelly B. ;
Derr, Rachel L. ;
Wolff, Antonio C. ;
Brancati, Frederick L. .
DIABETES CARE, 2010, 33 (04) :931-939
[4]   Long-term All-Cause Mortality in Cancer Patients With Preexisting Diabetes Mellitus A Systematic Review and Meta-analysis [J].
Barone, Bethany B. ;
Yeh, Hsin-Chieh ;
Snyder, Claire F. ;
Peairs, Kimberly S. ;
Stein, Kelly B. ;
Derr, Rachel L. ;
Wolff, Antonio C. ;
Brancati, Frederick L. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2008, 300 (23) :2754-2764
[5]   Improving outcome prediction in individuals with colorectal cancer and diabetes by accurate assessment of vascular complications: Implications for clinical practice [J].
Birch, Rebecca J. ;
Downing, Amy ;
Finan, Paul J. ;
Howell, Simon ;
Ajjan, Ramzi A. ;
Morris, Eva J. A. .
EJSO, 2021, 47 (05) :999-1004
[6]   Landmark Analysis at the 25-Year Landmark Point [J].
Dafni, Urania .
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2011, 4 (03) :363-U216
[7]  
Ergul Adviye, 2012, Endocrine Metabolic & Immune Disorders-Drug Targets, V12, P148
[8]  
Health Insurance Review and Assessment Service, 2022, G000CU7202219 HLTH I
[9]  
Higgins J., 2021, Cochrane Handbook for Systematic Reviews of Interventions version 6.3
[10]   Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2017 [J].
Hong, Seri ;
Won, Young-Joo ;
Park, Young Ran ;
Jung, Kyu-Won ;
Kong, Hyun-Joo ;
Lee, Eun Sook .
CANCER RESEARCH AND TREATMENT, 2020, 52 (02) :335-350